Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Grant Instruments Celebrates 60th Birthday

Published: Friday, July 13, 2012
Last Updated: Thursday, July 12, 2012
Bookmark and Share
Company has eyes fixed firmly on the future.

Grant Instruments has been celebrating its 60th birthday in recent weeks but is keen to use the occasion to look forward to the future rather than looking back.

Ludo Chapman, managing director of Grant Instruments - his father Cecil Chapman co-founded the company with Peter Ward back in 1952 - is determined to keep all eyes focused on the future.

He said: “It’s a remarkable achievement to have traded successfully for 60 years but it is not the time to look back now. We need to continue to leverage our unrivalled expertise in heating and cooling technology and temperature control to maintain our leadership position in the scientific instrumentation market.”

For the last six decades, Grant has been designing, manufacturing and distributing scientific products including water baths, block heaters and coolers, baths/circulators and re-circulating chillers, thermoshakers, rockers, rotators and shakers, centrifuges and vortex mixers.

Over this time, Grant has also developed a successful data acquisition business and more recently has diversified its offering by applying its scientific expertise to the development of sous vide cooking baths for the catering industry, a rapidly growing market that will play an important role for the company going forward.

“The market is changing rapidly and our over reliance on the UK and European markets has led us to look further east for our future growth and prosperity - we now have operations in Shanghai (China) and Bangalore (India) and will be looking to find further agile partners to grow our business in these regions in particular,” added Ludo Chapman.

Chapman continued, “Clearly, we have built a great reputation and that is testament to the hard work of our committed staff team but a new Grant is now emerging and the watchwords of this business will be quality, innovation, agility and customer focus!”

Grant Instruments began life making water baths for laboratories in a building at the bottom of the garden of the Old Vicarage in Grantchester, Cambridge, England, hence the company name.

Headquartered at Shepreth, Cambridgeshire, England, it now has operations in three continents and an extensive network of dealers and distributors servicing Europe, the Americas, and the Asia Pacific region.

“We have a great history and there have been some incredible successes over the last 60 years,” said Mr Chapman.

Mr Chapman continued, “However, we now need to refocus, use our exceptional expertise and market knowledge to continue to work with customers - as we did for the launch of our Optima water bath range earlier this year - so that we really understand the heating and cooling challenges of technicians and researchers in the modern laboratory. That’s the key to our success and survival!!”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Grant Instruments wins VWR UK Supplier of the Year Award 2013
Award recognizes suppliers who deliver significant sales growth, outstanding customer and technical service, product training and sales support to VWR’s UK organization.
Monday, March 10, 2014
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!